insider24.ch
Back to the feed

Shareholding disclosure

Eaton Vance Emerald Worldwide Health Science Fund

inBerna Biotech AG

Declared position

13.69%

Threshold

Crossed upwards

Timeline

Published

14.12.2005

Transaction

—

Voting rights breakdown

Voting rights acquired13.69%
Voting rights sold0%
Below threshold0%

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

T3878D3670

Beneficial owner

Eaton Vance Emerald Worldwide Health Science Fund

Declared address

Eaton Vance Emerald Worldwide Health Science Fund

Die OrbiMed Gruppe (OrbiMed Advisors LCC und OrbiMed Capital LLC) hält direkt und indirekt 13.69% über ihre unterliegende Funds. Davon hält der Eaton Vance Emerald Worldwide Health Science Fund direkt 8.08% (entsprechend 3'040'000 Namenaktien). Die OrbiMed Gruppe wird durch Sam D. Isaly, US-New York kontrolliert.

Open shareholder profileOpen company profile

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open